HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life

- HER2-Positive Metastatic Breast Cancer, in the Context of COVID-19 - Biomarker, Genomic & Diagnostic Testing: Grade & Hormone Receptors - Standard Treatment Options, including Targeted Therapy - How Biomarker Testing Informs Treatment Decisions - New & Emerging Targeted Treatments - Updates on Investigational New Drugs in Clinical Trials - How Research Contributes to Your Treatment Options - What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Neuropathy, Pain & Long-Term Effects - The Increasing Role of Telemedicine/Telehealth Appointments - Guidelines to Prepare for Telemedicine/Telehealth Appointments, including Technology, List of Questions & OpenNotes Discussion - Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns - Questions for Our Panel of Experts